Logan Vincent, MD
Interventional Cardiology · Portland, ORNPI 1164764288
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $27,825 of the $42,310 with a category attached, or 65.8%. Edwards Lifesciences accounts for 82.6% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $20,913, more than ten times the $121 reported in 2019.
Across 149 payments — averaging $283.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$35K
- Abbott$3K
- Medtronic$3K
- Ancora Heart, Inc.$675
- Boston Scientific$226
- Impulse Dynamics (USA) Inc.$125
- plus $167 from 3 others
Across 31 payments — averaging $2066.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Edwards Lifesciences$53K
- Abbott$11K
What the payments were for
- Consulting fees$27,82566%
- Travel & lodging$8,35220%
- Food & beverage$6,13214%
- Education$10%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 73 | $34,966 |
| Abbott | 34 | $3,218 |
| Medtronic | 31 | $2,933 |
| Ancora Heart, Inc. | 5 | $675 |
| Boston Scientific | 2 | $226 |
| Impulse Dynamics (USA) Inc. | 1 | $125 |
| Philips North America LLC | 1 | $121 |
| Teleflex LLC | 1 | $26 |
| Cardiac Dimensions, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Edwards SAPIEN 3 Transcatheter Heart Valve$15,867
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$12,720
- COREVALVE EVOLUT R$1,916
- MitraClip$1,241
- SAPIEN 3 Ultra RESILIA$1,157
- TRICLIP$1,076
- PASCAL$767
- AccuCinch$582
- EVOQUE$486
- OPTIMIZER$250
- GENERAL - STRUCTURAL HEART$144
- IGT D Coronary$121
- NAVITOR$102
How this compares
$42,310 in reported general payments places this provider in the 85th percentile of 68 interventional cardiology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $11,185 |
| Atorvastatin Calcium | 25 | $268 |
| ClopidogrelClopidogrel Bisulfate | 28 | $233 |
| Metoprolol Succinate | 16 | $190 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Portland
- Jason WollmuthPortland$749K
- Ethan KorngoldPortland$407K
- Amish DesaiPortland$186K
- Harsh GolwalaPortland$105K
- Brandon JonesPortland$101K
- Kathryn DawsonPortland$57K
- Amged AbdelazizPortland$38K
- Richard SohnPortland$38K
- Daniel FeldmanPortland$36K
- Kris KumarPortland$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.